•
Dec 31, 2023

Reneo Pharmaceuticals Q4 2023 Earnings Report

Total Revenue
$0
EPS
-$0.71
Previous year: -$0.55
+29.1%
Gross Profit
$0
Cash and Equivalents
$103M
Previous year: $19.9M
+416.7%
Free Cash Flow
-$19.8M
Previous year: -$15.9M
+24.7%
Total Assets
$107M
Previous year: $108M
-0.7%

Reneo Pharmaceuticals

Reneo Pharmaceuticals